From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady is joined by Amplia Therapeutics (ASX:ATX) CEO & MD Dr Christopher Burns & Bell Potter Analyst Thomas Wakim to unpack the ongoing clinical trials for their prospective treatment drug for pancreatic cancer, and its substantial market opportunities in the US.

Morning Bell 5 March

Jessica Amir
March 5, 2020

Market Update 4 March

Jessica Amir
March 4, 2020

Morning Bell 3 March

Jessica Amir
March 3, 2020

Morning Bell 2 March

Jessica Amir
March 2, 2020

February Market Overview

Jessica Amir
February 28, 2020

Morning Bell 28 February

Jessica Amir
February 28, 2020

Morning Bell 27 February

Jessica Amir
February 27, 2020

Market Update 26 February

Jessica Amir
February 26, 2020

Morning Bell 25 February

Jessica Amir
February 25, 2020